» Articles » PMID: 11178608

Acute Urinary Retention and Surgery for Benign Prostatic Hyperplasia: the Patient's Perspective

Overview
Journal Can J Urol
Specialty Urology
Date 2001 Apr 5
PMID 11178608
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

It is now possible to reduce the risk of acute urinary retention (AUR) and prostate surgery in patients suffering from symptomatic benign prostatic hyperplasia (BPH) with medical therapy. The objective of this study was to determine the concern and perceived impact on quality of life (QoL) of these potential events in patients at risk. Seventy-four consecutive patients with a diagnosis of BPH, but no history of AUR or prostate surgery referred to a single urology practice completed an AUA/BPH symptom index (AUA-SI), AUA BPH impact index, QoL assessment, and a comprehensive questionnaire (before and after counseling). This questionnaire explored their concern and opinion regarding the perceived impact of AUR or surgery on their personal QoL. Sixty-two patients (mean age 69.5) with an average AUA BPH Symptom Index of 12.2 were eligible for analysis. Over half of the patients were significantly concerned about the prospect of AUR (57%) and two thirds of the patients (67%) were significantly concerned about the prospect of surgery. However, more patients considered the insertion of a catheter for acute urinary retention would be more detrimental to their quality of life than surgery (68% vsersus 45%). More patients believed that catheterization would be more of a problem in their life than surgery (69% versus 52%). Patients with BPH at risk for future acute urinary retention and surgery generally felt that the potential occurrence of these events were of a major concern and if they occurred would be an important event affecting their personal quality of life.

Citing Articles

Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia.

Husted M, Gray D, Golding S, Hindley R Qual Health Res. 2022; 32(13):1979-1992.

PMID: 36154347 PMC: 9629511. DOI: 10.1177/10497323221129262.


Modern advancements in minimally invasive surgical treatments for benign prostatic obstruction.

Pascoe J, Fontaine C, Hashim H Ther Adv Urol. 2021; 13:17562872211030832.

PMID: 34349840 PMC: 8287272. DOI: 10.1177/17562872211030832.


Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia.

McVary K, Holland B, Beahrs J Prostate Cancer Prostatic Dis. 2019; 23(2):303-308.

PMID: 31740738 PMC: 7237346. DOI: 10.1038/s41391-019-0187-5.


Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group".

Weibl P, Klatte T, Laurinc P, Tomaskin R, Shariat S, Helbich M Wien Klin Wochenschr. 2014; 127(9-10):363-8.

PMID: 25447967 DOI: 10.1007/s00508-014-0668-4.


Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management.

Emberton M, Cornel E, Bassi P, Fourcade R, Gomez J, Castro R Int J Clin Pract. 2008; 62(7):1076-86.

PMID: 18479366 PMC: 2440415. DOI: 10.1111/j.1742-1241.2008.01785.x.